Endpoints News 生物医药· Anna Brown·· 2026-10-12AI 评分31
Undecimal Bio 携 1800 万美元融资成立,计划将 siRNA 拓展至肝外疾病
Undecimal Bio launches with $18M to take siRNA beyond liver disease
AI 导读
Eleven Therapeutics 将业务拆分,Undecimal Bio 携带 1800 万美元融资正式成立,目标是把 siRNA 技术拓展至肝脏以外的疾病领域。
正文
After spinning out one half of its business this summer, Eleven Therapeutics is carving out the other half with $18 million to join companies like …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news